Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 July 2008, Vol. 112, No. 2, pp. 277-286.
Prepublished online as a Blood First Edition Paper on March 4, 2008; DOI 10.1182/blood-2007-11-124545.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2007-11-124545v1
112/2/277    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chapel, H.
Right arrow Articles by Hammarstrom, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapel, H.
Right arrow Articles by Hammarstrom, L.
Related Collections
Right arrow Immunobiology
Right arrow Free Research Articles
Right arrow Clinical Trials and Observations
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL TRIALS AND OBSERVATIONS

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

Helen Chapel1, Mary Lucas1, Martin Lee2, Janne Bjorkander3, David Webster4, Bodo Grimbacher4,5, Claire Fieschi6, Vojtech Thon7, Mohammad R. Abedi8,9, and Lennart Hammarstrom9

1 Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; 2 Department of Biostatistics, University of California at Los Angeles; 3 Department of Immunology and Allergy, Sahlgrenska University Hospital, Gothenberg, Sweden; 4 Department of Immunology, Royal Free Hospital, London, United Kingdom; 5 Department of Immunology and Rheumatology, University of Freiburg, Freiburg, Germany; 6 Department of Medicine, Saint-Louis Hospital, Paris, France; 7 Department of Clinical Immunology, Masaryk University, Brno, Czech Republic; 8 Department of Transfusion Medicine, Örebro University Hospital, Örebro, Sweden; and 9 Department of Clinical Immunology, Karolinska Institute at KUS Huddinge, Stockholm, Sweden

The European Common Variable Immunodeficiency Disorders registry was started in 1996 to define distinct clinical phenotypes and determine overlap within individual patients. A total of 7 centers contributed patient data, resulting in the largest cohort yet reported. Patients (334), validated for the diagnosis, were followed for an average of 25.6 years (9461 patient-years). Data were used to define 5 distinct clinical phenotypes: no complications, autoimmunity, polyclonal lymphocytic infiltration, enteropathy, and lymphoid malignancy. A total of 83% of patients had only one of these phenotypes. Analysis of mortality showed a considerable reduction in the last 15 years and that different phenotypes were associated with different survival times. Types of complications and clinical phenotypes varied significantly between countries, indicating the need for large, international registries. Ages at onset of symptoms and diagnosis were shown to have a Gaussian distribution, but were not useful predictors of phenotype. The only clinical predictor was polyclonal lymphocytic infiltration, which was associated with a 5-fold increased risk of lymphoid malignancy. There was widespread variation in the levels of serum immunoglobulin isotypes as well as in the percentages and absolute numbers of B cells, confirming the heterogeneity of these conditions. Higher serum IgM and lower circulating CD8 proportions were found to be predictive markers for polyclonal lymphocytic infiltration and autoimmunity, respectively.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

T-cell homeostasis: the dark(ened) side of common variable immunodeficiency
Antonello Giovannetti, Marina Pierdominici, and Fernando Aiuti
Blood 2008 112: 446. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
U. Salzer, C. Bacchelli, S. Buckridge, Q. Pan-Hammarstrom, S. Jennings, V. Lougaris, A. Bergbreiter, T. Hagena, J. Birmelin, A. Plebani, et al.
Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes
Blood, February 26, 2009; 113(9): 1967 - 1976.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Giovannetti, M. Pierdominici, and F. Aiuti
T-cell homeostasis: the dark(ened) side of common variable immunodeficiency
Blood, July 15, 2008; 112(2): 446 - 446.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020